IDPL modernises tablet making unit at Gurgaon plant

 
Ananth Kumar said that his department is working on ‘Make-In-India’ mantra and this unit of IDPL is a step in that direction. Assuring the government’s full support in enhancing the efficiency and productivity of the public sector undertakings (PSUs), Ananth Kumar said that providing affordable and good quality medicines to masses of the country is important and the public sector undertakings have an important role to play as they are not driven by profit motive but also serve public interest.
 
He assured that the PSUs will not be sold. Instead, a model will be developed for leveraging their assets to make them financially sustainable. The Minister said that a task force will be set up soon to look into all these aspects. Ananth Kumar informed that Jan Aushadhi will be revamped, while steps are being taken to set up pharma clusters, pharma parks and medical devices parks in the country.

 
Dr V K Subburaj, secretary, Department of Pharmaceuticals, said, “Besides affordability and availability, quality of the medicines is also important. The government is taking policy initiatives so that more and more Indian pharmaceutical companies become compliant to the WHO Quality Standards. The drugs provided by IDPL and other PSUs will facilitate in smooth functioning of the government’s programmes and help provide access to people of good quality medicines.”